FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gerard Espinosa

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Jose A Gómez-Puerta; Gerard Espinosa; Ricard Cervera
Catastrophic antiphospholipid syndrome: diagnosis and management in pregnancy.
Antonio-Javier Chamorro; Antonia Calvo; Ricard Cervera; Ignacio Hernández-García; Miguel Marcos; Juan-Carlos Mejia; Gerard Espinosa
Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behçet's disease: a systematic review and meta-analysis.
María Carmen Cénit; Gerard Espinosa; J L Fernandez-Sueiro; Francisco J García-Hernandez; María Francisca González-Escribano; Miguel A González-Gay; Ana Hidalgo; Cesar Magro; José L Callejas; M Camps; Santos Castañeda; María Jesús Castillo Palma; Norberto Ortego Centeno; Enrique Raya; Roser Solans; Javier Martín
Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gerard Espinosa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jose A Gómez-Puerta; Gerard Espinosa; Ricard Cervera
Catastrophic antiphospholipid syndrome: diagnosis and management in pregnancy.
Clinics in laboratory medicine 2013;33(2):391-400.
2013: Antonio-Javier Chamorro; Antonia Calvo; Ricard Cervera; Ignacio Hernández-García; Miguel Marcos; Juan-Carlos Mejia; Gerard Espinosa
Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behçet's disease: a systematic review and meta-analysis.
Autoimmunity reviews 2013;12(5):607-16.
2013: María Carmen Cénit; Gerard Espinosa; J L Fernandez-Sueiro; Francisco J García-Hernandez; María Francisca González-Escribano; Miguel A González-Gay; Ana Hidalgo; Cesar Magro; José L Callejas; M Camps; Santos Castañeda; María Jesús Castillo Palma; Norberto Ortego Centeno; Enrique Raya; Roser Solans; Javier Martín
Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease.
Human immunology 2013;74(2):230-3.
2013: Gerard Espinosa; José A Gomez-Puerta; Guillermo Pons-Estel; Ignasi Rodríguez-Pintó; Ricard Cervera
Relapsing catastrophic antiphospholipid syndrome potential role of microangiopathic hemolytic anemia in disease relapses.
Seminars in arthritis and rheumatism 2013;42(4):417-23.
2012: C Catoggio; Ricard Cervera; A Alvarez-Uría; P L Fernandez; Gerard Espinosa
Catastrophic antiphospholipid syndrome triggered by fulminant disseminated herpes simplex infection in a patient with systemic lupus erythematosus.
Lupus 2012;21(12):1359-61.
2012: Daniela Perra; Raquel Ríos-Fernández; Marina Mesquida; Norberto Ortego; Alfredo Adán; Marco A Alba; José Luis Callejas; Ricard Cervera; Gerard Espinosa
Adalimumab for the treatment of Behçet's disease: experience in 19 patients.
Rheumatology (Oxford, England) 2012;51(10):1825-31.
2012: Ricard Cervera; Gerard Espinosa
Connective tissue diseases: classification criteria for SLE: the latest-but not least-attempt.
Nature reviews. Rheumatology 2012;8(9):506-7.
2012: Antonio-Javier Chamorro; Miguel Marcos; JA Mirón Canelo; Ricard Cervera; Gerard Espinosa
Val247Leu β2-glycoprotein-I allelic variant is associated with antiphospholipid syndrome: systematic review and meta-analysis.
Autoimmunity reviews 2012;11(10):705-12.
2012: Ricard Cervera; Gerard Espinosa
Update on the catastrophic antiphospholipid syndrome and the "CAPS Registry".
Seminars in thrombosis and hemostasis 2012;38(4):333-8.
2012: J M Antón; P Castro; Ricard Cervera; Gerard Espinosa; M Gandía; M Marcos; R Merchán; J M Nicolás
Mortality and long term survival prognostic factors of patients with systemic autoimmune diseases admitted to an intensive care unit: a retrospective study.
Clinical and experimental rheumatology 2012;30(3):338-44.
2012: María Teruel; Madelon C Vonk; Alexandre E Voskuyl; Torsten Witte; Timothy R D J Radstake; Gabriela Riemekasten; Annemie J Schuerwegh; CP Simeon; Paolo Airó; Lorenzo Beretta; Jasper Broen; Maria Teresa Camps; Patricia Carreira; Esmeralda Delgado-Frías; Jörg H W Distler; Gerard Espinosa; Maria Gallego; Rosa García-Portales; Miguel Angel González-Gay; Nicolas Hunzelmann; Bobby P Koeleman; Alexander Kreuter; Thomas Krieg; Claudio Lunardi; Javier Martin
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis.
Arthritis research & therapy 2012;14(3):R154.
2012: Lara Bossini-Castillo; Jasper C Broen; María T Camps; María del Carmen Freire; Patricia Carreira; Maria J Castillo; Meng May Chee; Christopher P Denton; Gerard Espinosa; Carmen Fonseca; Miguel A González-Gay; Ariane Herrick; Roger Hesselstrand; Anna-Maria Hoffmann-Vold; Bobby Pc Koeleman; Alexander Kreuter; Claudio Lunardi; Javier Martin; Javier Narváez; Timothy Rdj Radstake; Raquel Ríos-Fernández; Annemie J Schuerwegh; CP Simeon; Carlos Tolosa; Jacob M van Laar; Madelon C Vonk; Torsten Witte; Emma Beltrán; Lorenzo Beretta
A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis.
Arthritis research & therapy 2012;14(2):R85.
2012: Maria Angeles Martinez-Zamora; Sara Peralta; Joan Carles Reverter; Dolors Tassies; Francisco Carmona; Ricard Cervera; Montserrat Creus; Gerard Espinosa; Juan Balasch
Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case-control study.
Annals of the rheumatic diseases 2012;71(1):61-6.
2011: Guillermo J Pons-Estel; Gabriel E Salerni; Rosa M Serrano; José A Gomez-Puerta; Miguel Lozano; Miguel A Plasin; Edelweiss Aldasoro; Ricard Cervera; Joan Cid; Gerard Espinosa
Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: report of 31 cases and review of the literature.
Autoimmunity reviews 2011;10(11):679-84.
2011: M Marcos; J Mensa; A Soriano; J A Martínez; M Almela; Ricard Cervera; C Fernández; F Marco; Gerard Espinosa
Epidemiology and clinical outcomes of bloodstream infections among lupus patients.
Lupus 2011;20(9):965-71.
2011: Gerard Espinosa; Vicente Fonollosa; Xavier Muñoz; Miguel Ángel Plasín; Carmen Pilar Simeón; Ricard Cervera; Antoni Xaubet; Miquel Vilardell
Efficacy of cyclophospamide in the treatment of interstitial lung disease associated with systemic sclerosis.
Archivos de bronconeumología 2011;47(5):239-45.
2011: Ricard Cervera; M G Tektonidou; Gerard Espinosa; A R Cabral; E B González; Doruk Erkan; S Vadya; H E Adrogué; M Solomon; G Zandman-Goddard; Yehuda Shoenfeld
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations.
Lupus 2011;20(2):174-81.
2011: Ricard Cervera; M G Tektonidou; Gerard Espinosa; A R Cabral; E B González; Doruk Erkan; S Vadya; H E Adrogué; M Solomon; G Zandman-Goddard; Yehuda Shoenfeld
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions.
Lupus 2011;20(2):165-73.
2010: Gerard Espinosa; Ricard Cervera
Belimumab, a BLyS-specific inhibitor for the treatment of systemic lupus erythematosus.
Drugs of today (Barcelona, Spain : 1998) 2010;46(12):891-9.
2010: Ricard Cervera; Gerard Espinosa
Antiphospholipid syndrome: long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies.
Expert opinion on therapeutic targets 2010;14(12):1279-82.
2010: M Angeles Martínez-Zamora; Dolors Tassies; Francisco Carmona; Gerard Espinosa; Ricard Cervera; Joan Carles Reverter; Juan Balasch
Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies.
Journal of reproductive immunology 2010;86(2):133-40.
2010: Alfredo Adán; Victoria Hernandez; Santiago Ortiz; Juan Jose Molina; Laura Pelegrin; Gerard Espinosa; Raimon Sanmartí
Effects of infliximab in the treatment of refractory posterior uveitis of Behçet's disease after withdrawal of infusions.
International ophthalmology 2010;30(5):577-81.
2010: Gerard Espinosa; Isabel Blanco; Juan Miguel Antón; Marcelo Sánchez; Paolo Macchiarini; Joan Albert Barberà
Chronic thromboembolic pulmonary hypertension in Behçet's disease: effectiveness of endarterectomy.
Clinical and experimental rheumatology 2010;28(4 Suppl 60):S79-81.
2010: Gerard Espinosa; Ricard Cervera
Antiphospholipid syndrome: frequency, main causes and risk factors of mortality.
Nature reviews. Rheumatology 2010;6(5):296-300.
2010: Alex Smithson; Rafael Perello; Jesus Aibar; Gerard Espinosa; Dolors Tassies; Carolina Freire; Pedro Castro; Belen Suarez; Francisco Lozano; Josep-Maria Nicolas
Genotypes coding for low serum levels of mannose-binding lectin are underrepresented among individuals suffering from noninfectious systemic inflammatory response syndrome.
Clinical and vaccine immunology : CVI 2010;17(3):447-53.
2010: Gerard Espinosa; Andrea Mendizábal; Sonia Mínguez; Cristina Ramo-Tello; Jaume Capellades; Alejandro Olivé; Ricard Cervera
Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients.
Seminars in arthritis and rheumatism 2010;39(4):246-56.
2010: Gerard Espinosa; Ricard Cervera
Recent trends in the management of antiphospholipid syndrome (Hughes syndrome).
Drugs of today (Barcelona, Spain : 1998) 2010;46(1):39-47.
2009: Maria Angeles Martinez-Zamora; Dolors Tassies; Francisco Carmona; Gerard Espinosa; Ricard Cervera; Joan Carles Reverter; Juan Balasch
Thrombin activatable fibrinolysis inhibitor and clot lysis time in pregnant patients with antiphospholipid syndrome: relationship with pregnancy outcome and thrombosis.
American journal of reproductive immunology (New York, N.Y. : 1989) 2009;62(6):381-9.
2009: Silvia Bucciarelli; Gerard Espinosa; Ricard Cervera
The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome.
Lupus 2009;18(10):905-12.
2009: Gerard Espinosa; Ricard Cervera
Morbidity and mortality in the antiphospholipid syndrome.
Current opinion in pulmonary medicine 2009;15(5):413-7.
2009: D C Balderramo; O García; J Colmenero; Gerard Espinosa; Xavier Forns; P Ginès
Antiphospholipid syndrome during pegylated interferon alpha-2a therapy for chronic hepatitis C.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2009;41(7):e4-7.
2009: Silvia Bucciarelli; Doruk Erkan; Gerard Espinosa; Ricard Cervera
Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse.
Clinical reviews in allergy & immunology 2009;36(2-3):80-4.
2009: Gerard Espinosa; Ricard Cervera
Thromboprophylaxis and obstetric management of the antiphospholipid syndrome.
Expert opinion on pharmacotherapy 2009;10(4):601-14.
2009: Gloria de la Red; Dolors Tàssies; Gerard Espinosa; Joan Monteagudo; Albert Bové; Joan Plaza; Ricard Cervera; Joan Carles Reverter
Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
Thrombosis and haemostasis 2009;101(2):312-6.
2009: José A Gómez-Puerta; Gerard Espinosa; R Morlà; Maria C Cid; Ricard Cervera
Interstitial lung disease as a presenting manifestation of microscopic polyangiitis successfully treated with mycophenolate mofetil.
Clinical and experimental rheumatology 2009;27(1):166-7.
2008: Xavier Bosch; Antonio Guilabert; Gerard Espinosa; Eduard Mirapeix
Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo?
Trends in immunology 2008;29(6):280-9.
2008: Sònia Jiménez; D Tàssies; Gerard Espinosa; Angeles García-Criado; J Plaza; Joan Monteagudo; Ricard Cervera; Joan Carles Reverter
Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus.
Annals of the rheumatic diseases 2008;67(6):835-40.
2008: Gerard Espinosa; Silvia Bucciarelli; Ronald A Asherson; Ricard Cervera
Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors.
Seminars in thrombosis and hemostasis 2008;34(3):290-4.
2008: Gerard Espinosa; Ricard Cervera
Antiphospholipid syndrome.
Arthritis research & therapy 2008;10(6):230.
2007: Wolfgang Miesbach; Ronald A Asherson; Ricard Cervera; Y Shoenfeld; J Gomez Puerta; Gerard Espinosa; Silvia Bucciarelli
The role of malignancies in patients with catastrophic anti-phospholipid (Asherson's) syndrome.
Clinical rheumatology 2007;26(12):2109-14.
2007: Xavier Bosch; Antonio Guilabert; Gerard Espinosa; Eduard Mirapeix
Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review.
JAMA : the journal of the American Medical Association 2007;298(6):655-69.
2007: Gloria García-Segarra; Gerard Espinosa; Dolors Tassies; Josep Oriola; Jesús Aibar; Albert Bové; Pedro Castro; Joan Carles Reverter; Josep-Maria Nicolás
Increased mortality in septic shock with the 4G/4G genotype of plasminogen activator inhibitor 1 in patients of white descent.
Intensive care medicine 2007;33(8):1354-62.
2007: Ricard Cervera; Silvia Bucciarelli; Gerard Espinosa; José A Gómez-Puerta; Manuel Ramos-Casals; Yehuda Shoenfeld; Jean-Charles Piette; Ronald A Asherson
Catastrophic antiphospholipid syndrome: lessons from the "CAPS Registry"--a tribute to the late Josep Font.
Annals of the New York Academy of Sciences 2007;1108():448-56.
2007: José A Gómez-Puerta; Ricard Cervera; Gerard Espinosa; Ronald A Asherson; Mario García-Carrasco; Izaias P da Costa; Danieli C O Andrade; Eduardo F Borba; Alexander Makatsaria; Silvia Bucciarelli; Manuel Ramos-Casals; Josep Font
Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases.
Annals of the rheumatic diseases 2007;66(6):740-6.
2007: Ricard Cervera; Gerard Espinosa; Aida Cordero; M Rosa Oltra; Ainhoa Unzurrunzaga; Tomeu Rossiñol; Joan Plaza; Silvia Bucciarelli; Manuel Ramos-Casals; Miguel Ingelmo; Ronald A Asherson; Josep Font
Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS.
Seminars in arthritis and rheumatism 2007;36(5):287-96.
2007: Ulas D Bayraktar; Doruk Erkan; Silvia Bucciarelli; Gerard Espinosa; Ronald A Asherson
The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus.
The Journal of rheumatology 2007;34(2):346-52.
2007: Mario García-Carrasco; C Galarza; M Gómez-Ponce; Ricard Cervera; Jorge Rojas-Rodríguez; Gerard Espinosa; Silvia Bucciarelli; José A Gómez-Puerta; Albert Bové; Ricardo O Escárcega; Josep Font
Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients.
Lupus 2007;16(5):366-73.
2006: José A Gómez-Puerta; Ricard Cervera; Gerard Espinosa; Silvia Bucciarelli; Josep Font
Pregnancy and puerperium are high susceptibility periods for the development of catastrophic antiphospholipid syndrome.
Autoimmunity reviews 2006;6(2):85-8.
2006: Ricard Cervera; Gerard Espinosa; Silvia Bucciarelli; José A Gómez-Puerta; Josep Font
Lessons from the catastrophic antiphospholipid syndrome (CAPS) registry.
Autoimmunity reviews 2006;6(2):81-4.
2006: Silvia Bucciarelli; Ricard Cervera; Gerard Espinosa; José A Gómez-Puerta; Manuel Ramos-Casals; Josep Font
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors.
Autoimmunity reviews 2006;6(2):72-5.
2006: Gerard Espinosa; Silvia Bucciarelli; Ricard Cervera; José A Gómez-Puerta; Josep Font
Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome.
Autoimmunity reviews 2006;6(2):68-71.
2006: Silvia Bucciarelli; Gerard Espinosa; Ricard Cervera; Doruk Erkan; José A Gómez-Puerta; Manuel Ramos-Casals; Josep Font; Ronald A Asherson
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients.
Arthritis and rheumatism 2006;54(8):2568-76.
2006: José A Gómez-Puerta; Gerard Espinosa; José M Miró; Omar Sued; Josep M Llibre; Ricard Cervera; Josep Font
Behçet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy.
The Israel Medical Association journal : IMAJ 2006;8(7):513-4.
2006: José A Gómez-Puerta; Ricard Cervera; Gerard Espinosa; Sira Aguiló; Silvia Bucciarelli; Manuel Ramos-Casals; Miguel Ingelmo; Ronald A Asherson; Josep Font
Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients.
Seminars in arthritis and rheumatism 2006;35(5):322-32.
2006: Oscar Miró; Emilio Salgado; Santiago Tomás; Gerard Espinosa; Cristina Estrada; Carles Martí; Josep Camp; Miguel A Asenjo; Joan M Salmerón; Miquel Sánchez
[Direct discharge from triage in emergency departments: assessment, risks and patient satisfaction].
Medicina clínica 2006;126(3):88-93.
2006: Silvia Bucciarelli; Gerard Espinosa; Ronald A Asherson; Ricard Cervera; Gisela Claver; José A Gómez-Puerta; Manuel Ramos-Casals; Miguel Ingelmo
The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients.
Annals of the rheumatic diseases 2006;65(1):81-6.
2005: Ricard Cervera; Josep Font; José A Gómez-Puerta; Gerard Espinosa; M Cucho; Silvia Bucciarelli; Manuel Ramos-Casals; Miguel Ingelmo; Jean-Charles Piette; Yehuda Shoenfeld; Ronald A Asherson
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome.
Annals of the rheumatic diseases 2005;64(8):1205-9.
2005: Gerard Espinosa; Juan I Arostegui; Susana Plaza; Josefa Rius; Ricard Cervera; Jordi Yagüe; Josep Font
Behçet's disease and hereditary periodic fever syndromes: casual association or causal relationship?
Clinical and experimental rheumatology 2005;23(4 Suppl 38):S64-6.
2005: Felix Perez-Villa; Josep Font; Manel Azqueta; Gerard Espinosa; Carles Pare; Ricard Cervera; Joan Carles Reverter; Miguel Ingelmo; Gines Sanz
Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study.
Arthritis and rheumatism 2005;53(3):460-7.
2005: Ronald A Asherson; Gerard Espinosa; Ricard Cervera; José A Gómez-Puerta; J Musuruana; Silvia Bucciarelli; Manuel Ramos-Casals; A L Martínez-González; Miguel Ingelmo; Joan Carles Reverter; Josep Font; Douglas A Triplett
Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients.
Annals of the rheumatic diseases 2005;64(6):943-6.
2005: Oscar Miró; Xavier Jiménez-Fábrega; Núria Díaz; Blanca Coll-Vinent; Ernest Bragulat; Sònia Jiménez; Gerard Espinosa; José Hernández-Rodríguez; Fernando García Alfranca; M Teresa Alvarez; Jordi Salvador; José Millá; Miquel Sánchez
[Basic cardiopulmonary resuscitation program for high school students (PROCES). Results from the pilot program].
Medicina clínica 2005;124(1):4-9.
2005: José A Gómez-Puerta; Ricard Cervera; L M Calvo; Beatriz Gómez-Ansón; Gerard Espinosa; Gisela Claver; Silvia Bucciarelli; Albert Bové; Manuel Ramos-Casals; Miguel Ingelmo; Josep Font
Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients.
Rheumatology (Oxford, England) 2005;44(1):95-9.
2004: Ricard Cervera; Ronald A Asherson; M L Acevedo; José A Gómez-Puerta; Gerard Espinosa; Gloria de la Red; Victor Gil; Manuel Ramos-Casals; Mario García-Carrasco; Miguel Ingelmo; Josep Font
Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients.
Annals of the rheumatic diseases 2004;63(10):1312-7.
2004: Oscar Miró; Miquel Sánchez; Gerard Espinosa; José Millá
Quality and effectiveness of an emergency department during weekends.
Emergency medicine journal : EMJ 2004;21(5):573-4.
2004: Gerard Espinosa; Silvia Bucciarelli; Ricard Cervera; M Lozano; Joan Carles Reverter; Gloria de la Red; Victor Gil; Miguel Ingelmo; Josep Font; Ronald A Asherson
Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies.
Annals of the rheumatic diseases 2004;63(6):730-6.
2003: Blanca Coll-Vinent; Xavier Sala; Carme Fernández; Ernest Bragulat; Gerard Espinosa; Oscar Miró; José Millá; Miquel Sánchez
Sedation for cardioversion in the emergency department: analysis of effectiveness in four protocols.
Annals of emergency medicine 2003;42(6):767-72.
2003: Miquel Sánchez; Oscar Miró; Blanca Coll-Vinent; Ernest Bragulat; Gerard Espinosa; Elisenda Gómez-Angelats; Sònia Jiménez; Carme Queralt; José Hernández-Rodríguez; Josep R Alonso; José Millá
[Emergency department overcrowding: quantification of associated factors].
Medicina clínica 2003;121(5):161-72.
2003: Gerard Espinosa; Ricard Cervera; Josep Font; Yehuda Shoenfeld
Antiphospholipid syndrome: pathogenic mechanisms.
Autoimmunity reviews 2003;2(2):86-93.
2003: Oscar Miró; Miquel Sánchez; Gerard Espinosa; Blanca Coll-Vinent; Ernest Bragulat; José Millá
Analysis of patient flow in the emergency department and the effect of an extensive reorganisation.
Emergency medicine journal : EMJ 2003;20(2):143-8; discussion 148.
2003: Gerard Espinosa; Eugénia Santos; Ricard Cervera; Jean-Charles Piette; Gloria de la Red; Victor Gil; Josep Font; Robert Couch; Miguel Ingelmo; Ronald A Asherson
Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients.
Medicine 2003;82(2):106-18.
2003: Gerard Espinosa; Ricard Cervera; Josep Font; Ronald A Asherson
Adrenal involvement in the antiphospholipid syndrome.
Lupus 2003;12(7):569-72.
2002: Josep Font; Gerard Espinosa; Dolors Tàssies; Marc Pino; Munther A Khamashta; Teresa Gallart; Ricard Cervera; Gines Escolar; G R V Hughes; Miguel Ingelmo; Antonio Ordinas; Joan Carles Reverter
Effects of beta2-glycoprotein I and monoclonal anticardiolipin antibodies in platelet interaction with subendothelium under flow conditions.
Arthritis and rheumatism 2002;46(12):3283-9.
2002: Gerard Espinosa; Josep Font; FJ Muñoz-Rodríguez; Ricard Cervera; Miguel Ingelmo
Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship?
Clinical rheumatology 2002;21(4):309-13.
2002: Gerard Espinosa; Ricard Cervera; Joan Carles Reverter; Dolors Tàssies; Josep Font; Miguel Ingelmo
Vascular involvement in Behçet's disease.
The Israel Medical Association journal : IMAJ 2002;4(8):614-6.
2002: Ronald A Asherson; Gerard Espinosa; Ricard Cervera; Josep Font; Joan Carles Reverter
Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2002;8(3):157-65.
2002: Gerard Espinosa; Oscar Miró; Miquel Sánchez; Blanca Coll-Vinent; José Millá
Effects of external and internal factors on emergency department overcrowding.
Annals of emergency medicine 2002;39(6):693-5.
2002: Gerard Espinosa; Ricard Cervera; Josep Font; Ronald A Asherson
The lung in the antiphospholipid syndrome.
Annals of the rheumatic diseases 2002;61(3):195-8.
2002: FJ Muñoz-Rodríguez; Joan Carles Reverter; Josep Font; Dolors Tàssies; Gerard Espinosa; Ricard Cervera; Francisco Carmona; J Balsch; Miguel Ingelmo; Antonio Ordinas
Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus.
Lupus 2002;11(11):730-5.
2002: Oscar Miró; Santiago Nogué; Gerard Espinosa; Jordi To-Figueras; Miquel Sánchez
Trends in illicit drug emergencies: the emerging role of gamma-hydroxybutyrate.
Journal of toxicology. Clinical toxicology 2002;40(2):129-35.
2002: Gerard Espinosa; Josep Font; Dolors Tàssies; Antonio Vidaller; Ramon Deulofeu; Alfonso López-Soto; Ricard Cervera; Antonio Ordinas; Miguel Ingelmo; Joan Carles Reverter
Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
The American journal of medicine 2002;112(1):37-43.
2001: R A Asherson; Ricard Cervera; J C Piette; Y Shoenfeld; Gerard Espinosa; Michelle Petri; E Lim; T C Lau; A Gurjal; Anna Jedryka-Góral; Hanna Chwalinska-Sadowska; R J Dibner; Jorge Rojas-Rodríguez; Mario García-Carrasco; J T Grandone; A L Parke; P Barbosa; carlos vasconcelos; Manuel Ramos-Casals; Josep Font; Miguel Ingelmo
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients.
Medicine 2001;80(6):355-77.
2001: Gerard Espinosa; Josep Font; J C García-Pagan; Dolors Tàssies; Joan Carles Reverter; Carles Gaig; Francisco Cervantes; Ricard Cervera; Jaime Bosch; Miguel Ingelmo
Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients.
Medicine 2001;80(6):345-54.
2001: Gerard Espinosa; Dolors Tàssies; Josep Font; FJ Muñoz-Rodríguez; Ricard Cervera; Antonio Ordinas; Joan Carles Reverter; Miguel Ingelmo
Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis.
Seminars in arthritis and rheumatism 2001;31(1):12-20.
2001: Gerard Espinosa; S Nogué; J To-Figuera; Miquel Sánchez; Blanca Coll-Vinent
[Liquid ecstasy poisoning: study of 22 cases].
Medicina clínica 2001;117(2):56-8.
2001: Miquel Sánchez; G Mestre; Blanca Coll-Vinent; Ernest Bragulat; Gerard Espinosa; N Soler; R Gotsens; José Millá
[Impact in the quality of health care and cost-effectiveness analysis of the reform of an emergency medicine service].
Medicina clínica 2001;117(1):7-11.
2000: Dolors Tàssies; Gerard Espinosa; FJ Muñoz-Rodríguez; Carolina Freire; Ricard Cervera; Joan Monteagudo; Santiago Maragall; Gines Escolar; Miguel Ingelmo; Antonio Ordinas; Josep Font; Joan Carles Reverter
The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome.
Arthritis and rheumatism 2000;43(10):2349-58.
2000: Gerard Espinosa; FJ Muñoz-Rodríguez; Ricard Cervera; Josep Font
[The etiopathogenic role of hepatitis virus C in the antiphospholipid syndrome].
Medicina clínica 2000;115(9):357-8.
2000: FJ Muñoz-Rodríguez; Joan Carles Reverter; Josep Font; Dolors Tàssies; Ricard Cervera; Gerard Espinosa; Francisco Carmona; J Balasch; Antonio Ordinas; Miguel Ingelmo
Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Haematologica 2000;85(6):632-7.
1999: FJ Muñoz-Rodriguez; Josep Font; Ricard Cervera; Joan Carles Reverter; Dolors Tàssies; Gerard Espinosa; Alfonso López-Soto; Francisco Carmona; J Balasch; Antonio Ordinas; Miguel Ingelmo
Clinical study and follow-up of 100 patients with the antiphospholipid syndrome.
Seminars in arthritis and rheumatism 1999;29(3):182-90.
1997: S Reino; FJ Muñoz-Rodriguez; Ricard Cervera; Gerard Espinosa; Josep Font; Miguel Ingelmo
Optic neuropathy in the "primary" antiphospholipid syndrome: report of a case and review of the literature.
Clinical rheumatology 1997;16(6):629-31.
1997: Ricard Cervera; Mario García-Carrasco; Josep Font; M Ramos; Joan Carles Reverter; FJ Muñoz; Carlos Miret; Gerard Espinosa; Miguel Ingelmo
Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients.
Clinical and experimental rheumatology 1997;15(4):361-5.
1997: M Ramos; Ricard Cervera; Mario García-Carrasco; Carlos Miret; FJ Muñoz; Gerard Espinosa; Josep Font; Miguel Ingelmo
[Primary Sjögren's syndrome: clinical and immunologic study of 80 patients].
Medicina clínica 1997;108(17):652-7.
1997: Alfonso López-Soto; Ricard Cervera; Josep Font; Albert Bové; Joan Carles Reverter; FJ Muñoz; Carlos Miret; Gerard Espinosa; Antonio Ordinas; Miguel Ingelmo
Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
Clinical and experimental rheumatology 1997;15(2):143-9.
1997: Mario García-Carrasco; M Ramos; Ricard Cervera; Josep Font; J Vidal; FJ Muñoz; Carlos Miret; Gerard Espinosa; Miguel Ingelmo
Hepatitis C virus infection in 'primary' Sjögren's syndrome: prevalence and clinical significance in a series of 90 patients.
Annals of the rheumatic diseases 1997;56(3):173-5.